Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Generated: April 26, 2018

DrugPatentWatch Database Preview

Abbott Company Profile

« Back to Dashboard

What is the competitive landscape for ABBOTT, and what generic and branded alternatives to ABBOTT drugs are available?

ABBOTT has one hundred and fourteen approved drugs.

Summary for Abbott

US Patents:	0
Tradenames:	92
Ingredients:	65
NDAs:	114

Drugs and US Patents for Abbott

+ Get email alerts for changes to this table

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Abbott	AMINOSYN II 3.5% W/ ELECTROLYTES IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER	amino acids; calcium chloride; dextrose; magnesium chloride; potassium chloride; potassium phosphate, dibasic; sodium chloride	INJECTABLE;INJECTION	019714-001	Sep 12, 1988		DISCN	No	No		➤ Sign Up				➤ Sign Up
Abbott	A-HYDROCORT	hydrocortisone sodium succinate	INJECTABLE;INJECTION	089579-001	Apr 11, 1989		DISCN	No	No		➤ Sign Up				➤ Sign Up
Abbott	A-HYDROCORT	hydrocortisone sodium succinate	INJECTABLE;INJECTION	089580-001	Apr 11, 1989		DISCN	No	No		➤ Sign Up				➤ Sign Up
Abbott	VICOPRIN	aspirin; hydrocodone bitartrate	TABLET;ORAL	086333-001	Sep 14, 1983		DISCN	No	No		➤ Sign Up				➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration

Expired US Patents for Abbott

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Abbott	HYTRIN	terazosin hydrochloride	TABLET;ORAL	019057-001	Aug 7, 1987	5,412,095	➤ Sign Up
Abbott	HYTRIN	terazosin hydrochloride	TABLET;ORAL	019057-003	Aug 7, 1987	4,112,097	➤ Sign Up
Abbott	DEPAKOTE CP	divalproex sodium	TABLET, DELAYED RELEASE;ORAL	019794-002	Jul 11, 1990	4,988,731*PED	➤ Sign Up
Abbott	HYTRIN	terazosin hydrochloride	TABLET;ORAL	019057-003	Aug 7, 1987	4,251,532	➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration

Paragraph IV (Patent) Challenges for ABBOTT drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Capsules	10 mg and 15 mg	➤ Subscribe	2009-08-14
➤ Subscribe	Capsules	100 mg	➤ Subscribe	2012-10-31
➤ Subscribe	Tablets	100 mg	➤ Subscribe	2010-12-21

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS

Accenture

Teva

Moodys

Medtronic

Daiichi Sankyo

Federal Trade Commission

Fuji

Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.